5 Ht5A Receptor Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
HTR5A Protein - 5-HT5A Receptor Protein
| Protein Name | 5-HT5A Receptor Protein |
| Gene | HTR5A |
| UniProt ID | P47864 |
| PDB ID | None |
| Molecular Weight | 42 kDa |
| Subcellular Localization | Cell membrane, CNS |
| Protein Family | Serotonin receptor (Class A, GPCR) |
5-HT5A has the typical 7-transmembrane domain structure of class A GPCRs. It contains the conserved DRY motif and NPxxY motif. Unlike many other serotonin receptors, it has a relatively short C-terminal tail. Structural studies are limited due to challenges in expression and purification.
The 5-HT5A receptor is a Gi/o protein-coupled serotonin receptor that inhibits adenylyl cyclase, reducing cAMP production. It is one of the least characterized serotonin receptors. In the brain, it is involved in modulating circadian rhythm, sleep-wake cycles, and neuronal excitability. The receptor may exist as both monomer and dimer.
5-HT5A receptors are implicated in Alzheimer's disease, where altered signaling may contribute to sleep disturbances and circadian rhythm disruptions. Common variants have been associated with schizophrenia and major depression. The receptor may also play a role in migraine pathophysiology.
Selective 5-HT5A antagonists are being investigated for treating sleep disorders and migraine. Several compounds (e.g., AS-2674723) have shown activity in preclinical models. The receptor remains a relatively underexplored therapeutic target.
The study of 5 Ht5A Receptor Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] J. M. O'Donnell et al., "Serotonin receptor signaling in neurodegeneration," Neuropharmacology, vol. 135, pp. 316-328, 2018. PMID:29550372
[2] M. G. R. Nichols et al., "Metabotropic glutamate receptors in CNS disease," Brain Research, vol. 1683, pp. 1-16, 2018. PMID:29444698
This section provides an overview of the structure and function.
The 5-HT5A receptor exhibits distinct expression patterns in the brain:
The 5-HT5A receptor activates multiple intracellular pathways: